Recognizing the Patient
proved to be a busy month for the neurotechnology industry, as evidenced of Neurotech Business Report . If one theme stands out among the several groundbreaking studies and commercial developments this month, it is the importance of developing personalized therapies that are tailored to each patient. As we report in our coverage of the American Psychiatric Association meeting in San Francisco [see…
Biotronik Announces FDA Approval of Prospera SCS System
The market for spinal cord stimulation systems got a little more crowded this month when Biotronik, the German medtech manufacturer, announced FDA approval for its Prospera system. Biotronik is a major player in the cardiac devices market, where it competes with Medtronic, Boston Scientific, and Abbott—three incumbents in the SCS space. The company launched a new business segment called Biotronik Neuro, based in Lake Oswego, OR, to pursue the neuromodulation market.
CRM Industry Offers Insights for Bioelectronic Medicine
The global cardiac rhythm management industry, or more generally the field of cardiac bioelectronic implantable devices (CBID), offers an interesting showcase for examining the field of bioelectronic medicine. The evolution of the cardiac device industry can provide insights regarding dynamics that drove growth and altered competitive landscapes. If we examine this market and some of its inflection points this can inform us about opportunities and challenges faced today within bioelectronic medicine.
Interesting Times
Anyone reading this issue of Neurotech Business Report could easily come to the conclusion that these are interesting times in the neurotechnology industry. At a time when many healthtech startups are worried that the fountain of investment dollars we’ve seen in the last few years may be drying up, we report on at least four early-stage neurotech firms receiving funding [see Financial News, p7]. Sa…
Startups Meet with Investors and Strategics at LSI Medtech Conference
Neurotech Business Report More than 2,000 medical device industry executives, entrepreneurs, and investors assembled in Dana Point, CA earlier this month for the 2023 LSI Emerging Medtech Summit. The neurotech industry was well represented at the event. One of the unique features of this conference is the insight it offers into the dealmaking process. Several panel discussions featured medtech exec…
Boomerang Medical Gets Breakthrough Device Designation
Boomerang Medical, in Mountain View, CA, is a startup advancing the treatment of autoimmune diseases through bioelectronic medicine. They were founded in 2021, closed a $15 million Series A funding round in late 2022, and in early 2023, they announced breakthrough device designation from the FDA for their approach to treating Crohn’s disease and ulcerative colitis, the two most common forms of inflammatory bowel disease.
Vendors and Researchers Develop Flexible Brain Implants
One of the greatest challenges confronting vendors of brain implants such as DBS and BCI systems is developing devices that conform better with brain tissue. Almost all implanted neurostimulation devices on the market today are based on metal electrodes that come into contact with neural tissue. The better the contact, the more useful the device. Metal electrodes are stiffer than surrounding brain tissue, and are prone to all the mechanical impacts the human body is exposed to.
Neurotech Reports Releases New BioElectRx Market Forecasts
Neurotech Reports, the publisher of BioElectRx Business Report, released new market forecasts for the bioelectronic medicine industry in the years 2023-2028. Neurotech Reports editor James Cavuoto will preview the new data on April 4 at the 2023 Bioelectronic Medicine Forum in New York City. The full published report, The Market for Bioelectronic Medicine: 2023-2028 , will be available next month.
Pittsburgh Team Develops New Stroke Therapy Using SCS
A team of investigators from two Pittsburgh research institutions and a startup firm have developed a novel neurorehabilitation technology that may soon add to clinicians repertoire for treating stroke. While previous efforts at stroke rehabilitation have used vagus nerve stimulation, cortical stimulation, and surface stimulation strategies, the new approach uses spinal cord stimulation to improve arm and hand mobility.
Helen Mayberg to Keynote Sixth Annual Bioelectronic Medicine Forum in New York City
Helen Mayberg to Keynote Sixth Annual Bioelectronic Medicine Forum in New York City Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Sixth Annual Bioelectronic Medicine Forum will take place on April 4, 2023. The one-day event will be held at the New York Academy of Medicine in Manhattan. The keynote speaker at this yea…